LOS ANGELES, July 18, 2024 /PRNewswire/ — Eyenuk, a global artificial intelligence (AI) digital health company and leader in real-world applications for AI Eye Screening™ and AI Predictive Biomarkers™, today announced the appointment …
Eyenuk Appoints Bryan Haardt as Chief Executive Officer Read More »
January 6, 2021 – The Diabetes Care Journal just published a landmark study with patient data from the United States Department of Veterans Affairs (VA). In this multicenter, noninterventional study on …
December 7, 2020 – Eyenuk is pleased to announce that its EyeArt® AI System for autonomous diabetic retinopathy detection has been granted regulatory approval by INVIMA, the Colombian governmental regulatory …
November 30, 2020 – Gibraltar Health Authority, the provider of primary, secondary, and mental health to the citizens of Gibraltar recently adopted the EyeArt autonomous AI system for diabetic eye …
November 24, 2020 On its website, the World Health Organization (WHO) posted an article featuring the success of the “Preventing Blindness from Diabetic Retinopathy” project led by the Armenian EyeCare …
November 12, 2020 – The Temple University Health System recently expanded its point-of-care eye screening program to twelve general practice and internal medicine clinics throughout the city of Philadelphia. In …
A new article in the November/December 2020 edition of Retinal Physician talks about the benefits of EyeArt System over other screening methods including reduction in wait times and more time …
Artificial Intelligence Brings DR Screening Beyond Eye-Care Practices Read More »
Aug 25, 2020: Eyenuk, Inc. is honored to be highlighted by World Diabetes Foundation for phenomenal real-world clinical results delivered with Armenia Eye Care Project (AECP). Of the 16,000 people …
Eyenuk is honored to be featured as the latest “Small Business Success Story” by the National Institute of Health (NIH). Eyenuk’s innovations have been supported by significant grant funding from …
Eyenuk featured by NIH as the latest small business success story Read More »
EyeArt is the First FDA Cleared AI Technology for Autonomous Detection of Both More than mild and Vision-Threatening Diabetic Retinopathy Los Angeles, CA, August 5, 2020 — Eyenuk, Inc., a …
Artificial intelligence could help prevent eye damage and sight loss in people with diabetes and save NHS millions of pounds annually MONDAY 6THJULY 2020 Results from the largest study of …
Devlyn Optical Partnering with Eyenuk to Offer Diabetic Retinopathy Screening Los Angeles, CA, June 8, 2020 — Eyenuk, Inc. and Devlyn Optical, a spin-off of Grupo Devlyn, a multinational optical …
May 26, 2020 WebMD digital publication “Artificial intelligence and You” highlights Eyenuk innovations under the section “AI Already Transforms Medicine”. “A screening system developed by a California-based company called Eyenuk …
WebMD Publication Highlights Eyenuk AI Innovations Read More »
Researchers from Moorfields Eye Hospital, Homerton NHS Trust, and University College London find EyeArt System to have 100% sensitivity in detecting vision-threatening retinopathy Los Angeles, CA, May 19, 2020 — …
British Journal of Ophthalmology Publishes Strong EyeArt Accuracy Results Read More »
The Ophthalmology Innovation Summit (OIS) website has published an article titled, “Eyenuk’s EyeArt AI System Showing Its Value” highlighting Eyenuk’s recent success. Link to the full article on OIS.net website: …
Eyenuk Recent Success Featured on Ophthalmology Innovation Summit (OIS) Website Read More »
May 11, 2020: Amid the COVID-19 public health emergency, doctors are considering the use of telehealth-based care, as patients practice social distancing to avoid community spread. Prior to the current …
Partnering with Eyenuk to Identify At-Risk Patients Using Telemedicine and AI VIRGINIA BEACH, VA, May 4, 2020 —Wagner Macula & Retina Center (WMRC), a leading research and treatment center specializing …
Los Angeles, CA, April 27, 2020– Kaushal Solanki, Ph.D, Founder and CEO of Eyenuk, Inc. will present at the Eyecelerator Live Stream Series on Wednesday, April 29, 11:00am-12:30pm PT, in …
ENGLAND, April 15, 2020 — Eyenuk, Inc., a global artificial intelligence (AI) medical technology and services company and the leader in real-world applications for AI Eye Screening™, announced that it …
LOS ANGELES, April 2, 2020 — Eyenuk, Inc., a global artificial intelligence (AI) medical technology and services company and the leader in real-world applications for AI Eye Screening™, announced today …
Eyenuk Reports Strong First Quarter 2020 Commercial Results Read More »
KOLOA, Hawaii, USA – Jan 22, 2020 An article on Helio.com titled, “Eyenuk’s AI screening program detects referable diabetic retinopathy“, highlighted the Retina 2020 conference presentation by Dr. Michael S. …
